Orally Disintegrating Tablet (ODT) Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027
The global orally disintegrating tablet (ODT) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). According to the US Food and Drug Administration (FDA), ODT’s are a solid dosage form that contains a medicinal substance or active ingredient which rapidly disintegrates when placed upon the tongue within a second. The major factor for the growth of the global orally disintegrating tablet (ODT) market during the forecast period is the increasing demand for these tablets due to ease of use and new product launches.
For instance, in February
2022, Dr Reddy’s Laboratories Ltd. along with its subsidiaries announced the
launch of Lansoprazole DR Orally Disintegrating Tablets. These tablets are a
therapeutic equivalent generic version of Prevacid SoluTab delayed-release
orally disintegrating tablets, 15 mg and 30 mg, which is approved by the US
FDA. Additionally, in July 2021, SPI Pharma launched UltraBurst an orally
disintegrating tablet (ODT). Ultrabrust is an innovative excipient platform for
flash ODTs, which disintegrate in under ten seconds. Furthermore, in December
2021, Edenbridge Pharmaceuticals, LLC announced the approval of its New Drug
Application (NDA) for DARTISLA ODT (glycopyrrolate) orally disintegrating
tablets from the US FDA. DARTISLA ODT is an orally disintegrating tablet
available in 1.7 mg for the treatment of peptic ulcers in adults.
To Request a Sample of our Report on Orally
Disintegrating Tablet (ODT) Market: https://www.omrglobal.com/request-sample/orally-disintegrating-tablet-odt-market
Some major players in the market include Teva
Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others. The
market players are contributing significantly to the growth of the market by
the adoption of various strategies including mergers & acquisitions,
geographical expansion, partnerships and collaborations, and new product
launches, to stay competitive in the market. For instance, in November 2021,
Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a
strategic commercialization arrangement for rimegepant in markets outside of
the US. Rimegepant is commercialized as Nurtec ODT in the US and is used for
the treatment of episodic migraine in adults.
Market Coverage
• The market number available for –
2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
·
By Drug Class
·
By Disease Indication
·
By Distribution Channel
• Regions
Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape- Teva
Pharmaceutical Industries Ltd., Merck KGaA, and Mylan N.V., among others.
(Get 15% Discount on Buying this Report)
A
full Report Orally Disintegrating Tablet (ODT) Market is Available @ https://www.omrglobal.com/industry-reports/orally-disintegrating-tablet-odt-market
Global Orally Disintegrating Tablet (ODT) Market
Report by Segment
By Drug Class
• Anti-Psychotics
• Anti-Epileptics
• CNS Stimulants
• Anxiolytics
• Anti-Parkinsonian Drugs
• NSAIDS
• Anti-Allergy Drugs
• Others
By Disease Indication
• CNS Diseases
• GI Diseases
• CVS Disorders
• Allergy
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
Global Orally Disintegrating Tablet (ODT) Market
Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment